In a letter to the Medical Journal of Australia published today, a Monash University-led team is asking for hepatitis C virus patients to gain improved access to drugs to prevent liver related deaths.
Patients with non-alcoholic fatty liver disease (NAFLD) will benefit from a major multi-million euro European research project aimed at developing better diagnostic tests and treatments.
A team of researchers at the University of Michigan Health System has developed a risk prediction model that helps identify which hepatitis C patients have the most urgent need for new anti-viral drugs.
Suffering from anxiety or depression could carry an increased risk of death from liver disease, a study suggests.
Chronic liver diseases are steadily growing conditions, estimated to affect one in 10 Canadians. Most chronic liver diseases are "silent", attacking the liver for decades without symptoms until revealing ...